Trevi Therapeutics (TRVI) Change in Cash (2018 - 2026)
Trevi Therapeutics' quarterly Change in Cash came in at $498000.0 in Q1 2026, up 103.38% year-on-year from $244858.9 in Q1 2025, and up 101.31% quarter-over-quarter from -$38.0 million in Q4 2025.
Trevi Therapeutics has reported Change in Cash for 9 years, with the latest figure at $498000.0 in Q1 2026.
- For the quarter ending Q1 2026, Change in Cash rose 103.38% year-over-year to $498000.0; the trailing twelve-month figure through Mar 2026 stood at $38000.0 (down 99.32% YoY), and the FY2025 full-year result was -$15.2 million, down 993.12% from the prior year.
- Change in Cash for Q1 2026 stood at $498000.0, up from -$38.0 million in the prior quarter.
- The five-year high for Change in Cash was $97.7 million in Q2 2025, with the low at -$60.2 million in Q3 2025.
- Average Change in Cash over 5 years is -$1.0 million, with a median of -$848000.0 recorded in 2024.
- Peak annual rise in Change in Cash reached 11619.34% in 2025, while the deepest fall reached 2048.49% in 2025.
- Tracing TRVI's Change in Cash over 5 years: stood at -$54.0 million in 2022, then surged by 111.91% to $6.4 million in 2023, then jumped by 180.55% to $18.0 million in 2024, then sank by 310.34% to -$38.0 million in 2025, then surged by 101.31% to $498000.0 in 2026.
- The last three Change in Cash figures came in at $498000.0 (Q1 2026), -$38.0 million (Q4 2025), and -$60.2 million (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Cash (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | 2.44 Mn |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | 623.00 Mn |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | -2.44 Mn |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | 417.10 Mn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | -153.10 Mn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | 53.61 Mn |
| 10 | Trevi Therapeutics | 2.02 Bn | 1.85 Bn | - | 498,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 498,000.00 |
| Dec 31, 2025 | -37.96 Mn |
| Sep 30, 2025 | -60.19 Mn |
| Jun 30, 2025 | 97.68 Mn |
| Mar 31, 2025 | -14.72 Mn |
| Dec 31, 2024 | 18.05 Mn |
| Sep 30, 2024 | 3.09 Mn |
| Jun 30, 2024 | -848,000.00 |
| Mar 31, 2024 | -18.59 Mn |
| Dec 31, 2023 | 6.43 Mn |
| Sep 30, 2023 | 12.21 Mn |
| Jun 30, 2023 | 2.10 Mn |
| Mar 31, 2023 | -938,000.00 |
| Dec 31, 2022 | -53.99 Mn |
| Sep 30, 2022 | 41.88 Mn |
| Jun 30, 2022 | -4.42 Mn |
| Mar 31, 2022 | -7.72 Mn |
| Dec 31, 2021 | 7.51 Mn |
| Sep 30, 2021 | -7.11 Mn |
| Jun 30, 2021 | -5.15 Mn |
| Mar 31, 2021 | -3.43 Mn |
| Dec 31, 2020 | -8.29 Mn |
| Sep 30, 2020 | 9.11 Mn |
| Jun 30, 2020 | -8.46 Mn |
| Mar 31, 2020 | -4.67 Mn |
| Dec 31, 2019 | -6.20 Mn |
| Sep 30, 2019 | -7.87 Mn |
| Jun 30, 2019 | 58.44 Mn |
| Mar 31, 2019 | 5.74 Mn |
| Dec 31, 2018 | -6.33 Mn |
| Sep 30, 2018 | 6.48 Mn |
| Jun 30, 2018 | -8.90 Mn |
| Mar 31, 2018 | -6.06 Mn |